Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,670,440 papers from all fields of science
Search
Sign In
Create Free Account
hydrocortisone aceponate
Known as:
21-(acetyloxy)-11beta-hydroxy-17alpha-(propionyloxy)-4-pregnene-3,20-dione
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Hydrocortisone
analogs & derivatives
cytochrome P450 3A4 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Corrigendum to “Influence of a Diester Glucocorticoid Spray on the Cortisol Level and the CCR4+ CD4+ Lymphocytes in Dogs with Atopic Dermatitis: Open Study”
Masato Fujimura
,
Hironobu Ishimaru
Journal of Veterinary Medicine A
2014
Corpus ID: 263926076
[This corrects the article DOI: 10.1155/2014/492735.].
2011
2011
Use and abuse of glucocorticoids in veterinary dermatology Part 2: When to use and when not to use glucocorticoids
Anita Patel
2011
Corpus ID: 70406539
This paper describes the conditions for which systemic glucocorticoids are likely to be beneficial, along with appropriate dosage…
Expand
2010
2010
Hydrocortisone Aceponate Activity and Benefit/Risk Ratio in Relation to Reference Topical Glucocorticoids
J. Wohlrab
,
G. M. Beck
,
R. Neubert
,
U. Sischka
,
B. Kreft
Skin Pharmacology and Physiology
2010
Corpus ID: 24857090
The evaluation of the benefit/risk ratio (BRR) for topical glucocorticoids (TGC) allows the comparison of active ingredients and…
Expand
2010
2010
Effects of Repeated Topical Application of a 0.0584% Hydrocortisone Aceponate Spray on Skin Thickness in Beagle Dogs
C. Rème
,
P. Dufour
2010
Corpus ID: 27005364
This study evaluated the long-term cutaneous tolerance of a 0.0584% hydrocortisone aceponate spray (Cortavance ® ; Virbac) in…
Expand
2010
2010
A study to evaluate the efficacy and safety of hydrocortisone aceponate 0.127% lipophilic cream in steroid responsive dermatoses in Indian patients.
A. Mukhopadhyay
,
V. Baghel
Indian Journal of Dermatology, Venereology and…
2010
Corpus ID: 207456202
BACKGROUND Topical corticosteroids (CSs) are the mainstay of therapy in various steroid responsive dermatoses. Newer CSs are more…
Expand
2009
2009
Hydrocortisone aceponate is a potent and safe glucocorticoid.
V. Schmidt
,
N. McEwan
,
T. Nuttall
Veterinary dermatology (Print)
2009
Corpus ID: 42296279
2005
2005
Contact dermatitis to hydrocortisone aceponate in Efficort® cream inducing widespread reaction
F. Sayed
,
A. Ammoury
,
F. Launais
,
J. Bazex
Contact Dermatitis
2005
Corpus ID: 39608993
Algae Thymus vulgaris Acid Yellow 3 Juniperus communis Leaf Humulus Lupus (hops) Chromium oxide greens Lemon grass Mellissa…
Expand
1995
1995
Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblasts
H. C. Korting
,
E. Hülsebus
,
M. Kerscher
,
R. Greber
,
M. Schäfer-Korting
British Journal of Dermatology
1995
Corpus ID: 44281693
In inflammatory skin disease, hydrocortisone and prednisolone double esters are about equipotent to conventional medium potency…
Expand
1993
1993
Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids
Monika Schäfer‐körting
,
H. Korting
,
M. Kerscher
,
S. Lenhard
Clinical pharmacology and therapy
1993
Corpus ID: 31573172
Nonhalogenated double esters of prednisolone or hydrocortisone applied topically to the skin have a low atrophogenic potential…
Expand
1990
1990
[The effect of hydrocortisone aceponate on proliferation, total protein synthesis and collagen synthesis in human skin fibroblasts in vitro].
F. Görmar
,
A. Bernd
,
H. Holzmann
Arzneimittel-Forschung
1990
Corpus ID: 8114311
Effect of Hydrocortisone Aceponate on Proliferation, Total Protein Synthesis and Collagen Synthesis in Human skin Fibroblasts in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE